Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $96.7150 (-2.27%) ($96.3100 - $96.7150) on Mon. Aug. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.81% (three month average) | RSI | 42 | Latest Price | $96.7150(-2.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.8% a day on average for past five trading days. | Weekly Trend | LGND declines -2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(51%) IWN(50%) IWO(50%) IWC(48%) IBB(47%) | Factors Impacting LGND price | LGND will decline at least -1.405% in a week (0% probabilities). UUP(-17%) VXX(-16%) VIXM(-8%) TBT(-8%) UNG(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.405% (StdDev 2.81%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $101.65 | 5 Day Moving Average | $100.96(-4.2%) | 10 Day Moving Average | $102.45(-5.6%) | 20 Day Moving Average | $101.65(-4.85%) | To recent high | -10.2% | To recent low | 30% | Market Cap | $1.554b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |